Evolution of the Average Target: NextCure, Inc.

Evolution of the Target Price: NextCure, Inc.

Changes in Analyst Recommendations: NextCure, Inc.

67b1dd7e4231d13aaf787a5ae.2GG2rGROEOK6l-auLE6GkhZri14iy9hpIeu6ztb_Pus.j1LUmzU7Uo7J7oj6Wiqw_CY_5CtypL8eZ6fV-563Tb2OCc7cFyB3levnjQ~2b10dd13e53dcedfb24768a771d996ee

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+891.45%
+10.28%
+16.98%
+31.88%
+84.16%
+35.46%
+28.51%
-33.36%
-8.27%
+25.55%
Average +108.26%
Weighted average by Cap. +21.39%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.950USD
Average target price
19.33USD
Spread / Average Target
+891.45%
High Price Target
25.00USD
Spread / Highest target
+1,182.05%
Low Price Target
15.00USD
Spread / Lowest Target
+669.23%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Piper Sandler
Ladenburg Thalmann
Roth Capital Partners
Needham & Co.
BTIG
Truist Securities
BofA Securities
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.950USD
Average target price
19.33USD
Spread / Average Target
+891.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NXTC Stock
  4. Consensus NextCure, Inc.